Reflecting on 2022, and looking into the (RWE) crystal ball…
Future historians are likely to look back on 2022 as a year of political, economic, and climatic turbulence… as the year winds down, however, the team at Vitaccess are taking the opportunity to look back a little more fondly – at the past, present, and future of...
Join our ISPOR short course
Join Dr Mark Larkin, Dr Catherine Bottomley, and Dr Casey Quinn for the virtual ISPOR short course on Digital Real-World Evidence Generation Approaches in Rare Diseases and Oncology. The course is designed to provide a good understanding of how to plan and undertake...
Should I stay or should I go? Patient engagement and retention in real-world studies
In April 2022, Industry Standard Research conducted a survey on behalf of PPD (the clinical research business of Thermo Fisher Scientific) with 152 leaders of biotech and pharmaceutical organizations worldwide to gather their insights on industry trends. Not only did...
KIR#12 – Patient engagement and retention in real-world studies
Sam Llewellyn, Senior Consultant, and Dr Mark Larkin, CEO and Founder of Vitaccess, presented examples of real-world studies where patient retention strategies have been used, resulting in strong engagement. Suitable for all evidence generation stakeholders, they...
